Quality of Life, Depression, and Anxiety Among Hepatitis B Patients
dc.contributor.author | Keskin, Gulseren | |
dc.contributor.author | Gumus, Aysun Babacan | |
dc.contributor.author | Orgun, Fatma | |
dc.date.accessioned | 2019-10-27T22:08:17Z | |
dc.date.available | 2019-10-27T22:08:17Z | |
dc.date.issued | 2013 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | This descriptive cross-sectional study was designed to determine the depression and anxiety levels, and their effects, on quality of life of patients with chronic Hepatitis B. Chronic infection with Hepatitis B virus has a profound effect on health-related quality of life. Medications, including interferon, that are commonly used to treat chronic viral Hepatitis B may cause depression as an adverse effect. However, little is known about the impact of depression and anxiety on quality of life in patients with Hepatitis B. A total of 96 patients aged between 15 and 61 years were included in the study. Slightly more than half of them (52%) were female. Three scales-the Beck Depression Inventory, Beck Anxiety Scale, and Short Form of the World Health Organization Quality of Life Questionnaire (WHOQOL-BREF)-were used in the study. The scores obtained from the BDS in 91.7% of the patients were above the cutoff value of 17. Moreover, 80 patients received interferon. There was a negative correlation between the physical, environmental, and cultural areas on the Beck Anxiety Scale and WHOQOL-BREF (Turkish) (p <.05). A high level of depressive symptoms was established in this study, and the physical, environmental, and cultural aspects of quality of life were determined to increase as the anxiety level increased. | en_US |
dc.identifier.doi | 10.1097/SGA.0b013e3182a788cc | en_US |
dc.identifier.endpage | 356 | en_US |
dc.identifier.issn | 1042-895X | |
dc.identifier.issn | 1538-9766 | |
dc.identifier.issue | 5 | en_US |
dc.identifier.pmid | 24084133 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 346 | en_US |
dc.identifier.uri | https://doi.org/10.1097/SGA.0b013e3182a788cc | |
dc.identifier.uri | https://hdl.handle.net/11454/49158 | |
dc.identifier.volume | 36 | en_US |
dc.identifier.wos | WOS:000330364300005 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Gastroenterology Nursing | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Quality of Life, Depression, and Anxiety Among Hepatitis B Patients | en_US |
dc.type | Article | en_US |